India's Pharmaceutical Exports

Country Profile

El Salvador

El Salvador is an emerging destination for Indian pharmaceutical exports — $49.0M in FY 2025–26, with 5.6× growth over the past decade. Medicines accounts for 85% of shipments, with vaccines contributing $2.61M. The compound annual growth rate since FY2015 stands at 17.0%.

🇸🇻 $49.0M · 5.6× growth since FY2015 · 17.0% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$49.0M
Exports FY2025–26 DGCIS
5.6×
Growth FY2015→2026
17.0%
CAGR FY2015→2026
85%
Medicines Share
5
Product Categories Supplied
El Salvador is an emerging destination for Indian pharmaceutical exports — $49.0M in FY 2025–26, with 5.6× growth over the past decade. Medicines accounts for 85% of shipments, with vaccines contributing $2.61M. The compound annual growth rate since FY2015 stands at 17.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $41.5M (84.8%) Medicine Ingredients $3.49M (7.1%) Vaccines $2.61M (5.3%) Surgical & Hospital Supplies $1.14M (2.3%) Traditional & Herbal $210K (0.4%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to El Salvador in the RBI overseas direct investment dataset (2011–2026).